6472
COM:BORA-CORP
Bora Pharmaceuticals
- Stock
Last Close
780.00
22/11 04:17
Market Cap
86.08B
Beta: -
Volume Today
928.49K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|
revenue | 2.72B - | 5.30B 94.50% | 4.78B 9.77% | 3.14B 34.35% | 3.08B 2.01% | 3.21B 4.23% | 2.86B 10.86% | 5.03B 75.93% | |
cost of revenue | 1.82B - | 4.21B 130.78% | 2.85B 32.11% | 1.41B 50.47% | 1.43B 1.21% | 1.51B 5.42% | 1.35B 10.42% | 3.08B 127.61% | |
gross profit | 901.98M - | 1.09B 21.20% | 1.93B 76.15% | 1.72B 10.45% | 1.64B 4.66% | 1.70B 3.20% | 1.51B 11.25% | 1.95B 29.56% | |
selling and marketing expenses | 62.45M - | 107.25M 71.73% | 101.43M 5.43% | 94.29M 7.03% | 119.79M 27.04% | 131.59M 9.85% | 200.51M 52.37% | 288.99M 44.13% | |
general and administrative expenses | 167.78M - | 244.71M 45.85% | 221.44M 9.51% | 212.83M 3.89% | 242.57M 13.97% | 320.00M 31.92% | 319.91M 0.03% | 723.55M 126.17% | |
selling general and administrative expenses | 230.23M - | 351.95M 52.87% | 322.87M 8.26% | 307.12M 4.88% | 362.36M 17.99% | 451.59M 24.62% | 520.42M 15.24% | 1.01B 94.56% | |
research and development expenses | 28.42M - | 83.43M 193.52% | 55.42M 33.57% | 70.60M 27.38% | 62.71M 11.17% | 109.43M 74.50% | 93.53M 14.53% | 196.00M 109.57% | |
other expenses | -61.00M - | -280.96M 360.57% | -254.68M 9.35% | -417.12M 63.78% | 123.75M 129.67% | 112.84M 8.81% | |||
cost and expenses | 1.91B - | 4.82B 151.76% | 3.23B 32.89% | 1.79B 44.58% | 1.86B 3.60% | 2.07B 11.50% | 1.97B 5.04% | 4.28B 118.00% | |
operating expenses | 91.43M - | 612.47M 569.87% | 378.29M 38.24% | 377.72M 0.15% | 425.07M 12.54% | 561.01M 31.98% | 613.95M 9.44% | 1.21B 96.85% | |
interest expense | 44.00M - | 46.78M 6.32% | 41.40M 11.50% | 39.05M 5.67% | 32.25M 17.42% | 142.19M 340.91% | |||
ebitda | 711.91M - | 759.74M 6.72% | 1.62B 113.25% | 1.20B 25.71% | 1.11B 7.36% | 902.99M 19.01% | 1.21B 33.68% | 1.11B 8.30% | |
operating income | 643.33M - | 657.83M 2.25% | 1.49B 125.96% | 1.07B 28.30% | 964.42M 9.51% | 718.71M 25.48% | 1.02B 41.34% | 855.30M 15.80% | |
depreciation and amortization | 68.58M - | 101.91M 48.60% | 133.68M 31.17% | 137.76M 3.05% | 150.57M 9.30% | 184.28M 22.38% | 191.35M 3.84% | 251.62M 31.50% | |
total other income expenses net | 138.70M - | -221.94M 260.02% | -44.00M 80.17% | -46.78M 6.32% | -41.40M 11.50% | -39.05M 5.67% | -32.25M 17.42% | 656.51M 2,135.69% | |
income before tax | 782.03M - | 435.88M 44.26% | 1.44B 230.92% | 1.02B 29.35% | 923.02M 9.42% | 679.66M 26.37% | 983.54M 44.71% | 1.51B 53.71% | |
income tax expense | 207.90M - | 27.65M 86.70% | 399.17M 1,343.65% | 318.21M 20.28% | 178.26M 43.98% | 96.58M 45.82% | 239.88M 148.37% | 298.19M 24.31% | |
net income | 568.88M - | 403.87M 29.01% | 1.04B 157.35% | 692.03M 33.42% | 733.17M 5.94% | 565.61M 22.85% | 716.14M 26.61% | 1.17B 63.63% | |
weighted average shs out | 97.82M - | 100.35M 2.59% | 99.13M 1.22% | 100.43M 1.31% | 100.71M 0.28% | 101.23M - | 100.93M 0.30% | ||
weighted average shs out dil | 97.83M - | 101.09M 3.34% | 101.48M 0.38% | 102.03M 0.54% | 102.68M 0.64% | 105.04M - | 104.07M 0.93% | ||
eps | 5.82 - | 4.02 30.93% | 10.48 160.70% | 6.89 34.26% | 7.28 5.66% | 0 100% | 7.07 Infinity% | 11.61 64.21% | |
epsdiluted | 5.82 - | 3.99 31.44% | 10.26 157.14% | 6.78 33.92% | 7.14 5.31% | 0 100% | 6.88 Infinity% | 11.26 63.66% |
All numbers in (except ratios and percentages)